It’s not just money that is lacking. Successful development of medical therapeutics in Japan ー including vaccines ー takes transparency and ethical policies.
In Japan, Daiichi Sankyo began developing an mRA vaccine about the same time as Pfizer and Moderna, but the know-how to connect this society was lacking.
A new command center is setting out to promote the development of domestic vaccines through creation of a more supportive research and funding environment.
The news circulated like wildfire on December 2 when it was announced that the British pharmaceuticals regulator, the MHRA, had decided that the COVID-19 vaccine developed...
